WEST LAFAYETTE, Ind. — A researcher in Purdue University’s College of Science is developing a patent-pending platform technology that mimics the dual-layer structure of viruses to deliver nucleic acid ...

Recent developments in nanoparticle-mediated cancer immunotherapy promote treatment with less toxicity. Cancer immunotherapy utilizes a patient’s immune system to target and destroy cancer. Many types ...

Technology development focused on generating tools to advance nucleic acid-based research for functional genomics and gene-expression analysis to drive drug discovery and development and to develop ...

The use of the nucleic acid platform for antigen delivery has expanded rapidly in the past decade, highlighted by the ...

Earth’s most diverse biological entities are the viruses that infect bacteria, called bacteriophages (phages). They are rich resources for discovering proteins and tools for biotechnology, but many ...

Not all symptoms or signs occur in all cases and there are febrile or meningoencephalitic forms of some of the diseases (e.g., TBEV), which present and progress differently. For several of these ...

A researcher is developing a patent-pending platform technology called LENN that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells. A ...

Purdue University researcher David Thompson has developed LENN, a system to deliver nucleic acid-based therapies to targeted cancer cells. His and his team’s research into using LENN to deliver ...